Page 82 - CIBERES2016-ENG

leaD researcher
Pérez Vizcaíno, Francisco
Universidad Complutense de madrid
Facultad de Farmacia Ciudad Universitaria, S/N 28040 Madrid
(+34) 91 394 14 77 [email protected] group website
GROUP MEMBERS
Staff members: Barreira Barba, Bianca | Moreno Gutierrez, Laura
Associated members: Callejo Arranz, María | Cogolludo Torralba, Ángel Luis | Mondejar Parreño, Gema | Morales Cano, Daniel | Pandolfi, Rachele
Main lines of research
• Pulmonary hypertension is a condition characterized by increased pulmonary vascular resistance with a complex and not well characterized pathophysiology. Our interest is mainly focused on the mechanisms involved in pulmonary vasodilation and inhibition of cell proliferation in order to identify and design new drugs that are potentially useful in the treatment of pulmonary hypertension.
• Acute lung injury (ALI ) or its more severe form, acute respiratory distress syndrome (ARDS ) is characterized by pulmonary edema and alveolar collapse leading to severe arterial hypoxemia. Although the protective ventilatory support strategies have improved the prognosis of patients, the associated mortality remains unacceptably high. Our interest is to characterizie the pulmonary vascular inflammatory response associated with acute lung injury and the identification of therapeutic targets to improve prognosis in these patients.
• Our research work is focused in analyzing different signaling pathways involved in these pathologies:
1) Sphingolipids, components of the plasma membrane of all eukaryotic cells whose hydrolysis products (ceramides and sphingosine) play a key role in various signal transduction pathways. 2) Innate immunity receptors and danger-associated molecular patterns. 3) microRNAs
82
PROGRAMMES
Chronic Respiratory Diseases Diffuse Respiratory Diseases Infectious Respiratory Diseases